Anthony Sharp

1.0k total citations
17 papers, 847 citations indexed

About

Anthony Sharp is a scholar working on Molecular Biology, Immunology and Neurology. According to data from OpenAlex, Anthony Sharp has authored 17 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Neurology. Recurrent topics in Anthony Sharp's work include Heat shock proteins research (5 papers), Multiple Sclerosis Research Studies (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Anthony Sharp is often cited by papers focused on Heat shock proteins research (5 papers), Multiple Sclerosis Research Studies (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Anthony Sharp collaborates with scholars based in United States, Germany and United Kingdom. Anthony Sharp's co-authors include Douglas L. Feinstein, Paul Polak, Cinzia Dello Russo, Shao Xia Lin, Sergey Kalinin, Guy Weinberg, Jill Richardson, Lucia Lisi, Vitaliy Gavrilyuk and Michael T. Heneka and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neurochemistry and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Anthony Sharp

17 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Sharp United States 15 400 224 191 128 121 17 847
Clare A. Jones United Kingdom 13 264 0.7× 238 1.1× 190 1.0× 106 0.8× 86 0.7× 15 776
Silvia Belcredito Italy 12 405 1.0× 253 1.1× 230 1.2× 103 0.8× 187 1.5× 15 1.3k
Sofie Voet Belgium 7 593 1.5× 417 1.9× 348 1.8× 96 0.8× 172 1.4× 7 1.2k
Junwei Zeng China 18 439 1.1× 181 0.8× 253 1.3× 36 0.3× 154 1.3× 45 973
Keying Zhu China 16 426 1.1× 237 1.1× 143 0.7× 69 0.5× 87 0.7× 31 891
Lijie Feng China 18 400 1.0× 150 0.7× 143 0.7× 47 0.4× 85 0.7× 33 924
Mario Patrizio Italy 19 396 1.0× 275 1.2× 197 1.0× 39 0.3× 125 1.0× 32 973
P.J. Gebicke-Haerter Germany 11 257 0.6× 452 2.0× 197 1.0× 35 0.3× 83 0.7× 11 792
Shlomit Erlich Israel 12 593 1.5× 112 0.5× 65 0.3× 112 0.9× 128 1.1× 13 1.2k
Anneleen Spooren Belgium 8 202 0.5× 208 0.9× 149 0.8× 41 0.3× 94 0.8× 8 662

Countries citing papers authored by Anthony Sharp

Since Specialization
Citations

This map shows the geographic impact of Anthony Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Sharp more than expected).

Fields of papers citing papers by Anthony Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Sharp. The network helps show where Anthony Sharp may publish in the future.

Co-authorship network of co-authors of Anthony Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Sharp. A scholar is included among the top collaborators of Anthony Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Sharp. Anthony Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Boullerne, Anne I., Paul Polak, David J. Braun, et al.. (2014). Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis. Journal of Neurochemistry. 129(4). 696–703. 14 indexed citations
2.
Polak, Paul, Sergey Kalinin, David J. Braun, et al.. (2012). The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus. Journal of Neurochemistry. 121(2). 206–216. 25 indexed citations
3.
Lisi, Lucia, Pierluigi Navarra, Anthony Sharp, et al.. (2012). Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 243(1-2). 43–51. 54 indexed citations
4.
Lisi, Lucia, Susan O. McGuire, Anthony Sharp, et al.. (2012). The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE. Journal of Neuroimmunology. 255(1-2). 1–7. 10 indexed citations
5.
Polak, Paul, Sergey Kalinin, Anthony Sharp, et al.. (2012). Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis. Journal of Neuroinflammation. 9(1). 272–272. 11 indexed citations
6.
Lin, Shao Xia, Lucia Lisi, Cinzia Dello Russo, et al.. (2011). The Anti-Inflammatory Effects of Dimethyl Fumarate in Astrocytes Involve Glutathione and Haem Oxygenase-1. ASN NEURO. 3(2). 141 indexed citations
7.
Simonini, Maria Vittoria, Paul Polak, Anthony Sharp, et al.. (2009). Increasing CNS Noradrenaline Reduces EAE Severity. Journal of Neuroimmune Pharmacology. 5(2). 252–259. 60 indexed citations
8.
Ksendzovsky, Alexander, Douglas L. Feinstein, Anthony Sharp, et al.. (2009). Investigation of immunosuppressive mechanisms in a mouse glioma model. Journal of Neuro-Oncology. 93(1). 107–114. 20 indexed citations
9.
Sharp, Anthony, Paul Polak, Shao Xia Lin, et al.. (2008). P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 5(1). 33–33. 136 indexed citations
10.
Russo, Cinzia Dello, Paul Polak, Alessandra Spagnolo, et al.. (2006). The heat‐shock protein 90 inhibitor 17‐allylamino‐17‐demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. Journal of Neurochemistry. 99(5). 1351–1362. 63 indexed citations
11.
Kalinin, Sergey, Paul Polak, José L. M. Madrigal, et al.. (2006). Beta-Amyloid-Dependent Expression of NOS2in Neurons: Prevention by an α2-Adrenergic Antagonist. Antioxidants and Redox Signaling. 8(5-6). 873–833. 28 indexed citations
12.
Polak, Paul, Sergey Kalinin, Cinzia Dello Russo, et al.. (2005). Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 168(1-2). 65–75. 111 indexed citations
13.
Murphy, Patricia, Anthony Sharp, Joseph Shin, et al.. (2002). Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. Journal of Neuroscience Research. 67(4). 461–470. 32 indexed citations
14.
Feinstein, Douglas L., Patricia A. Murphy, Anthony Sharp, et al.. (2001). Local Anesthetics Potentiate Nitric Oxide Synthase Type 2 Expression in Rat Glial Cells. Journal of Neurosurgical Anesthesiology. 13(2). 99–105. 24 indexed citations
15.
Heneka, Michael T., et al.. (2001). The heat shock response reduces myelin oligodendrocyte glycoprotein‐induced experimental autoimmune encephalomyelitis in mice. Journal of Neurochemistry. 77(2). 568–579. 31 indexed citations
16.
Heneka, Michael T., et al.. (2000). The Heat Shock Response Inhibits NF-κB Activation, Nitric Oxide Synthase Type 2 Expression, and Macrophage/Microglial Activation in Brain. Journal of Cerebral Blood Flow & Metabolism. 20(5). 800–811. 57 indexed citations
17.
Stasiołek, Mariusz, Vitaliy Gavrilyuk, Anthony Sharp, et al.. (2000). Inhibitory and Stimulatory Effects of Lactacystin on Expression of Nitric Oxide Synthase Type 2 in Brain Glial Cells. Journal of Biological Chemistry. 275(32). 24847–24856. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026